Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia.
- 1 August 1975
- journal article
- review article
- Vol. 21 (2), 185-201
Abstract
No abstract availableThis publication has 81 references indexed in Scilit:
- FAILURE OF LOW-DOSE HEPARIN TO PREVENT DEEP-VEIN THROMBOSIS AFTER HIP-REPLACEMENT ARTHROPLASTYThe Lancet, 1974
- Cytotoxic effect of antisera on51Cr-labelled monolayers of skeletal muscleThe Journal of Pathology, 1973
- ANTI-MYOGLOBIN ANTIBODY IN POLYMYOSITISThe Lancet, 1972
- Localization and Properties of an Acid‐Solubl'e Muscle Antigen Reacting with Antibodies in Myasthenia Gravis SeraActa Pathologica Microbiologica Scandinavica Section B Microbiology and Immunology, 1972
- THYMIN: A THYMIC POLYPEPTIDE CAUSING THE NEUROMUSCULAR BLOCK OF MYASTHENIA GRAVIS*Annals of the New York Academy of Sciences, 1971
- Myogenesis in vitro as demonstrated by immunofluorescent staining with antimuscle serumExperimental Cell Research, 1971
- EXPERIMENTAL MYASTHENIA GRAVISThe Lancet, 1969
- EXPERIMENTAL AUTOIMMUNE THYMITIS AN ANIMAL MODEL OF HUMAN MYASTHENIA GRAVISThe Lancet, 1966
- Myasthenia GravisBMJ, 1963
- AUTO-IMMUNIZATION AND THE LESIONS OF AUTO-IMMUNITYMedicine, 1962